GSK3B and cancer: AZD5363 is an inhibitor targeting the kinase activity of the three Akt subtypes (Akt1, 2, and 3).215 AZD5363 inhibits cancer cell proliferation and phosphorylates GSK3β and the downstream channel protein S6 in vitro.